[1] 贾建平.神经病学[M].北京:人民卫生出版社,2010:205-206.
[2] Chiu HFK, Lam LCW, Chi I, et al. Prevalence of dementia in Chinese elderly in Hong Kong[J]. Neurology, 1998, 50(4): 1002.
[3] 何婷婷,张允岭,金香兰,等.中医药治疗血管性痴呆临床近况[J].北京中医药大学学报(中医临床版),2012,19(3):9-14.
[4] George A.American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders(DSM-IV)[M]. Forth Edition. Washington DC: American Psychiatric Publishing, 1994: 142-147.
[5] 国家中医药管理局.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002:91-99.
[6] Zhang MY, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education[J]. Ann Neurol, 1990, 27(4): 428-437.
[7] Voltz R, Rosen FV, Yousry T, et al. Reversible encephalopathy with cerebral wasospasm in a Guillain-Barre syndrome patient treated with intravenous immunoglobulin[J]. Neurology, 1996, 46(1): 250-251.
[8] Roman GG, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop[J]. Neurology, 1993, 43(2): 250-260.
[9] 田金洲,韩明向,涂晋文,等.血管性痴呆的诊断、辨证及疗效判定标准(研究用)[J].中国老年学杂志,2002,22(5):329-331.
[10] 马莉,姜欢,刘征.中医药治疗血管性痴呆研究进展[J].针灸临床杂志,2015,31(1):85.
[11] 宿佩勇,王健.桂枝茯苓丸研究进展[J].中药药理与临床,2015,31(1):357.
[12] 吴晓珺,顾铁保,和翔.大柴胡汤药理作用与临床运用综述[J].湖北中医杂志,2003,25(8):54-55.
[13] Murdoch J, Hall R. Brain protection: physiological and pharmacological consideration. Part I: The physiology of brain injury[J]. Can J Anesth, 1990, 37: 663.